GRIFOLS SA |
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 05:40pm | European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading | MT |
| 30/04 | Grifols Issues EUR1 Billion Notes Due 2030 | MT |
Chart calendar Grifols SA
80d6c5ea354decdb4047484387d6e._EhPfcKZTxXGTU1Gc9t-_Jp7EUkasn6_VCvJfI217Kk.zQx8HJv3FWzwfAInQ6tTufJLfjpi4BH4IE-RTefTs5CzfDgbkeAdUKFgOg~3b0a92e374c438f4a69286bb69a0fe58
Upcoming events on Grifols SA
Past events on Grifols SA
| 29/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 29/02/2024 | Q4 2023 Earnings Release Pre-market |
| 11/01/2024 07:00 pm | Business Update Call |
| 02/11/2023 06:00 pm | Q3 2023 Earnings Call |
| 02/11/2023 01:26 pm | Q3 2023 Earnings Release |
| 27/07/2023 06:00 pm | Q2 2023 Earnings Call |
| 27/07/2023 12:23 pm | Q2 2023 Earnings Release |
| 16/06/2023 03:30 pm | Annual General Meeting - Second Call |
| 15/06/2023 03:30 pm | Annual General Meeting - First Call |
| 09/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 09/05/2023 | Q1 2023 Earnings Release Pre-market |
| 28/02/2023 07:00 pm | Q4 2022 Earnings Call |
| 28/02/2023 | Q4 2022 Earnings Release Pre-market |
| 08/11/2022 07:00 pm | Q3 2022 Earnings Call |
| 08/11/2022 | Q3 2022 Earnings Release Pre-market |
| 28/07/2022 09:30 am | Interim 2022 Earnings Call |
| 28/07/2022 | Interim 2022 Earnings Release Pre-market |
| 30/06/2022 02:30 pm | Investor & Analyst Meeting |
| 10/06/2022 03:30 pm | Annual General Meeting - Second Call |
| 09/06/2022 03:30 pm | Annual General Meeting - First Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5 099 5 077 0.42% | 5 340 5 393 -0.99% | 4 933 5 177 -4.71% | 6 064 5 918 2.47% | 6 592 6 613 -0.32% | 7 098 |
|
EBITDA Million EUR | Released Forecast Spread | 1 407 1 418 -0.79% | 1 479 1 422 3.97% | 962 1 214 -20.79% | 1 221 1 231 -0.82% | 1 455 1 404 3.62% | 1 810 |
|
EBIT Million EUR | Released Forecast Spread | 1 131 1 129 0.2% | 996 1 094 -8.98% | 595 868 -31.47% | 806 837 -3.79% | 1 023 901 13.55% | 1 291 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 817 795 2.78% | 879 895 -1.82% | 350 651 -46.14% | 361 466 -22.5% | 224 360 -37.71% | 740 |
|
Net income Million EUR | Released Forecast Spread | 625 615 1.65% | 619 636 -2.74% | 183 434 -57.86% | 208 265 -21.32% | 59,3 142 -58.36% | 469 |
|
EPS EUR | Released Forecast Spread | 0,91 0,90 1.17% | 0,90 0,93 -3.07% | 0,27 0,61 -55.91% | 0,31 0,39 -19.94% | 0,09 0,22 -59.11% | 0,76 |
| Announcement Date | 27/02/20 | 26/02/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2 677 2 656 0.79% | 2 537 2 492 1.81% | 1 198 1 358 -11.78% | 2 396 2 481 -3.42% | 1 405 1 368 2.75% | 1 543 1 568 -1.59% | 2 810 2 717 3.42% | 1 541 1 575 -2.16% | 1 713 1 595 7.37% | 3 254 3 094 5.17% | 1 561 1 534 1.76% | 1 663 1 650 0.81% | 3 225 3 211 0.43% | 1 597 1 609 -0.72% | 1 770 1 756 0.8% | 1 640 | 1 765 | 1 747 | 1 840 |
|
EBITDA Million EUR | Released Forecast Spread | 731 638 14.7% | 635 612 3.61% | 327 524 -37.57% | 248 | 618 557 10.96% | 308 314 -1.94% | 294 341 -13.77% | 603 | 299 190 56.91% | 361 345 4.69% | 659 678 -2.66% | 374 368 1.51% | 426 433 -1.51% | 366 | 459 | 456 | |||
|
EBIT Million EUR | Released Forecast Spread | 422 396 6.39% | 464 459 1.04% | 132 276 -52.3% | 427 424 0.69% | 173 209 -17.08% | 177 224 -21.17% | 378 466 -18.81% | 176 86,0 104.43% | 254 236 7.67% | 264 245 7.78% | 329 307 7.21% | 230 | 339 | 336 | |||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 378 374 1.11% | -27,8 48,7 -157.08% | 228 250 -8.91% | 66,7 109 -38.87% | 46,9 113 -58.33% | 133 232 -42.51% | -84,2 -72,5 -16.1% | 103 76,9 34.22% | 19,0 -9,10 309.3% | 99,6 107 -7.19% | 105 149 -29.34% | 55,0 | 69,8 | 81,8 | 107 | ||||
|
Net income Million EUR | Released Forecast Spread | 218 209 4.52% | 267 254 5.07% | -84,0 5,28 -1692.64% | 144 163 -12.01% | 45,0 70,1 -35.81% | 20,1 48,7 -58.76% | 64,6 138 -53.05% | -108 -73,0 -48.31% | 52,0 35,5 46.6% | -56,2 -77,0 26.99% | 59,5 69,5 -14.35% | 56,0 100 -44.15% | 32,8 | 71,2 | 77,4 | 68,8 | |||
|
EPS EUR | Released Forecast Spread | 0,39 0,39 0% | 0,28 | -0,12 0,02 -614.36% | 0,21 0,34 -38.24% | 0,14 | 0,10 0,20 -50% | 0,04 | 0,08 0,06 33.33% | 0,08 | 0,12 | 0,07 | 0,18 | 0,17 | 0,05 | |||||
| Announcement Date | 30/07/20 | 29/07/21 | 28/02/22 | 28/02/22 | 28/07/22 | 28/07/22 | 28/07/22 | 08/11/22 | 28/02/23 | 28/02/23 | 09/05/23 | 27/07/23 | 27/07/23 | 02/11/23 | 28/02/24 | - | - | - | - |
| 02/05/2024 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 07/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 08/05/2024 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Grifols SA
- Stock Market
- Equities
- GRF Stock
- Stock
- Calendar Grifols SA
